688617.SH
APT Medical, Inc.
SSE · Healthcare · Medical - Devices · CN
CNY 255.45
−3.12%Year over year
Reported trailing growth
- Revenue
- +25.2%
- EBITDA
- —
- EBIT
- +22.6%
- EPS
- +20.7%
- Free cash flow
- +236.0%
- Operating cash flow
- +24.9%
Forward estimates
Based on analyst estimates
- Revenue
- +32.8%
- EBITDA
- +39.3%
- EPS
- +31.6%
Three-year CAGR
- Revenue
- +28.6%
- EBITDA
- +33.5%
- EBIT
- +33.5%
- Net income
- +31.9%
- EPS
- +2.7%
- Free cash flow
- +44.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026